Mutation analysis of RAD51D in non-BRCA1/2 ovarian and breast cancer families

A HRM-based screening method detects RAD51C germ-line deleterious mutations in Spanish breast and ovarian cancer families

(2011) Atocha Romero et al.   BREAST CANCER RESEARCH AND TREATMENT

Further evidence for the contribution of the RAD51C gene in hereditary breast and ovarian cancer susceptibility

(2011) Mikko Vuorela et al.   BREAST CANCER RESEARCH AND TREATMENT

RAD51C is a susceptibility gene for ovarian cancer

(2011) Liisa M. Pelttari et al.   HUMAN MOLECULAR GENETICS

Analysis of RAD51C germline mutations in high-risk breast and ovarian cancer families and ovarian cancer patients

(2011) Ella R. Thompson et al.   HUMAN MUTATION

Inherited Mutations in Breast Cancer Genes—Risk and Response

(2011) Andrew Y. Shuen et al.   JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA

Integrated genomic analyses of ovarian carcinoma

(2011) D. Bell et al.   NATURE

Germline mutations in RAD51D confer susceptibility to ovarian cancer

(2011) Chey Loveday et al.   NATURE GENETICS

Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene

(2010) Alfons Meindl et al.   NATURE GENETICS

Making the best of PARP inhibitors in ovarian cancer

(2010) Susana Banerjee et al.   Nature Reviews Clinical Oncology